Global Asset Management Group, Inc. (GAMG): M&A transaction — Kenilworth Systems acquires 60% of Regenecell; pivots to medical travel referral

Global Asset Management Group, Inc.

Issued 2M shares (3.8% of outstanding) to acquire 60% of Regenecell, a Florida medical travel consulting firm.
Regenecell founder Steven Swank retains 40% minority interest and serves as officer of the subsidiary.
Company had no operating revenue since 1998; acquisition ends shell status and establishes operating business.
Net loss of $126,906 for nine months ended Sept. 30, 2023; no revenue from operations.

item 2.01 item 3.02 item 5.01 item 5.02 item 5.06 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Global Asset Management Group, Inc.: The registrant ceased being a shell company upon completion of a share exchange transaction.

Change: shell status

Exact text from the filing

As a result of the completion of the share exchange transaction described in Item 2.01 (Completion of Acquisition or Disposition of Assets) of this current report on Form 8-K, which is incorporated herein in its entirety, we ceased being a “shell company,” as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended.

View on SEC.gov

M&A Transactions SEC 8-K Item 2.01/5.01 confidence 0.9

Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).

Action: acquisition
Counterparty: Regenecell, Inc.
Closing: 2023-09-30

Exact text from the filing

we acquired 60% of the issued and outstanding Common Stock of Regenecell, Inc.

View on SEC.gov

Browse all governance changes →

Global Asset Management Group, Inc. filing history →

Source: SEC EDGAR

accession 0001477932-23-008923

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.